SCHEMBL5386879

SCHEMBL5386879

Cc1cc(Cl)n2nc(-c3ccccc3Cl)c(I)c2n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
RAB9A P51151 4/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
HPGD P15428 1/20 0.40
CRHR1 P34998 1/20 0.40
NPC1 O15118 3/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 2/20 0.40
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GPR55 Q9Y2T6 1/20 0.36
LMNA P02545 2/20 0.36
HSD11B1 P28845 1/20 0.36
TSHR P16473 2/20 0.35
GLA P06280 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375242 0.80 MAPT (0.64) ALDH1A1KDM4ERAB9AMAPTKMT2A
SCHEMBL4840877 0.80 KMT2A (0.37) ALDH1A1RAB9AMAPTKMT2ACRHR1
SCHEMBL4843180 0.76 XDH (0.47) KDM4EKMT2APOLBTP53HSD17B10
SCHEMBL5375243 0.76 DPP4 (0.37) ALDH1A1KDM4ERAB9AMAPTHPGD
SCHEMBL20529181 0.75 MAPT (0.56) ALDH1A1KDM4ERAB9AMAPTKMT2A
SCHEMBL6517585 0.72 CNR1 (0.43) KMT2AMEN1POLBHSD11B1HSD17B10
SCHEMBL5381153 0.70 DPP4 (0.53) ALDH1A1KDM4ERAB9AMAPTKMT2A
SCHEMBL14577345 0.69 MEN1 (0.62) ALDH1A1KDM4ERAB9AMAPTKMT2A
SCHEMBL5391337 0.68 MAPT (0.49) ALDH1A1KDM4ERAB9AMAPTKMT2A
SCHEMBL4833434 0.68 CNR1 (0.43) ALDH1A1KDM4ERAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176210-B2 Cannabinoid receptor ligands and uses thereof PFIZER INC. (US) 2007-02-13 US disclosed
US-7176210-B2 Cannabinoid receptor ligands and uses thereof PFIZER INC. (US) 2007-02-13 US disclosed
US-7176210-B2 Cannabinoid receptor ligands and uses thereof PFIZER INC. (US) 2007-02-13 US disclosed
US-20040157838-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157838-A1 Cannabinoid receptor ligands and uses thereof CNR1, CNR2, GPR18 ALDH1A1 1683/4885KDM4E 3361/4885RAB9A 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.